Disc Medicine Inc (IRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -212,184 | -109,357 | -76,429 | -46,827 | -35,969 |
| Depreciation Amortization | -8,238 | -5,148 | 100 | 89 | 32 |
| Accounts payable and accrued liabilities | 1,070 | -4,681 | -3,741 | 526 | 1,315 |
| Other Working Capital | 3,526 | 3,231 | -2,953 | 2,125 | 1,286 |
| Other Operating Activity | 35,433 | 22,029 | 9,561 | 1,835 | 5,802 |
| Operating Cash Flow | $-180,393 | $-93,926 | $-73,462 | $-42,252 | $-27,534 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -933 | -505 | -89 | -151 | -68 |
| Purchase Of Investment | -849,585 | -386,627 | N/A | N/A | N/A |
| Sale Of Investment | 456,219 | 94,800 | N/A | N/A | N/A |
| Investing Cash Flow | $-394,299 | $-292,332 | $-89 | $-151 | $-68 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 28,988 | N/A | N/A | N/A |
| Common Stock Issued | 473,407 | 190,719 | 239,379 | 151,122 | 68 |
| Other Financing Activity | 0 | -1,393 | 0 | -2,144 | 89,861 |
| Financing Cash Flow | $473,407 | $218,314 | $239,379 | $148,978 | $89,929 |
| Beginning Cash Position | 192,672 | 360,616 | 194,788 | 88,213 | 25,886 |
| End Cash Position | 91,387 | 192,672 | 360,616 | 194,788 | 88,213 |
| Net Cash Flow | $-101,285 | $-167,944 | $165,828 | $106,575 | $62,327 |
| Free Cash Flow | |||||
| Operating Cash Flow | -180,393 | -93,926 | -73,462 | -42,252 | -27,534 |
| Capital Expenditure | -933 | -505 | -89 | -151 | -68 |
| Free Cash Flow | -181,326 | -94,431 | -73,551 | -42,403 | -27,602 |